A multiplexed point-of-care assay for C-reactive protein and N-terminal pro-brain natriuretic peptide
- 1 February 2011
- journal article
- research article
- Published by Elsevier in Analytical Biochemistry
- Vol. 409 (1) , 7-13
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular CausesNew England Journal of Medicine, 2008
- N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection StudyJACC, 2007
- C-Reactive ProteinCirculation, 2003
- Cardiac Troponin I Is Associated With Impaired Hemodynamics, Progressive Left Ventricular Dysfunction, and Increased Mortality Rates in Advanced Heart FailureCirculation, 2003
- Future of Biomarkers in Acute Coronary SyndromesCirculation, 2003
- Markers of Inflammation and Cardiovascular DiseaseCirculation, 2003
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective studyThe Lancet, 2001
- Prediction of Coronary Heart Disease Using Risk Factor CategoriesCirculation, 1998
- A multivariate analysis of the risk of coronary heart disease in FraminghamJournal of Chronic Diseases, 1967